Should we review the 12 week gap between 1st and 2nd dose?

Should we review the 12 week gap between 1st and 2nd dose?

Eleanor: I support current 12 week policy. 1st dose gives high level of protection for 12 weeks with Astroxeneca. Controversy with Pfizer as no data beyond 6 weeks in between doses. Need to weigh up delay with saving lives by getting 2 doses as close to each other as possible. Gov needs to keep monitoring and needs to review if 12 weeks does not work. In any case, 12 weeks is absolute max.

Points

Time will tell whether Scotland should be concerned over the recent "discussions" between the EU and their supply from AstraZeneca not impacting on our supply.

Back to group

This content is created by the open source Your Priorities citizen engagement platform designed by the non profit Citizens Foundation

Your Priorities on GitHub

Check out the Citizens Foundation website for more information